The team’s strategy—called antibody–ADC click—relies on the rapid ligation between trans‑cyclooctene (TCO) and tetrazine moieties. The post Modular Antibody–ADC Click Chemistry Overcomes Tumor Drug Resistance in Mice appeared first on GEN – Genetic Engineering and Biotechnology News.
You may also like
Genetic Study Links Excessive Sweating to Neurological...
Parkinson’s in the Clinic, Insilico enters Phase...
KRAS-Targeted Vaccine Crosses First Clinical Milestone...
Jasper gets a lifeline in merger with immune drugmaker...
Arbutus, Sanofi escalate mRNA patent fights;...
GSK shelves cough drug acquired in $2B deal
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.